Respiratory Virus Hospitalization Surveillance Network (RESP-NET) Content Implementation Guide
1.0.0 - STU 1 United States of America flag

This page is part of the Respiratory Virus Hospitalization Surveillance Network (RESP-NET) Content Implementation Guide (v1.0.0: STU1) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

ValueSet: RESP-NET Covid test codes (Experimental)

Official URL: http://hl7.org/fhir/us/resp-net/ValueSet/resp-net-labtest-covid-codes Version: 1.0.0
Standards status: Informative Computable Name: RESPNetCovidCodes
Other Identifiers: OID:2.16.840.1.113883.4.642.40.52.48.2

Usage:Reporting: Triggering, Priority: Routine

Copyright/Legal: This material contains content from LOINC (http://loinc.org). LOINC is copyright © 1995-2020, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license at http://loinc.org/license. LOINC® is a registered United States trademark of Regenstrief Institute, Inc. Current Procedural Terminology (CPT) is copyright 2020 American Medical Association. All rights reserved

List of Covid test codes

References

This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)

Logical Definition (CLD)

version: 1; Last updated: 2024-08-19 22:06:32+0000

Profile: US Public Health Triggering ValueSet

This value set includes codes based on the following rules:

  • Include these codes as defined in http://loinc.org
    CodeDisplay
    102048-6SARS coronavirus 2 & Respiratory syncytial virus Ag
    95941-1Influenza virus A & Influenza virus B & SARS coronavirus 2 & Respiratory syncytial virus RNA panel
    100861-4Cells.CD4+CD154+/Cells.CD4^after stimulation with SARS-CoV-2 Nucleocapsid peptide
    100858-0Cells.CD4+CD154+/Cells.CD4^after stimulation with SARS-CoV-2 Spike peptide
    100862-2Cells.CD4.Interferon gamma-expressing/Cells.CD4^after stimulation with SARS-CoV-2 Nucleocapsid peptide
    100859-8Cells.CD4.Interferon gamma-expressing/Cells.CD4^after stimulation with SARS-CoV-2 Spike peptide
    100863-0Cells.CD4.Tumor necrosis factor alfa-expressing/Cells.CD4^after stimulation with SARS-CoV-2 Nucleocapsid peptide
    100860-6Cells.CD4.Tumor necrosis factor alfa-expressing/Cells.CD4^after stimulation with SARS-CoV-2 Spike peptide
    95942-9Influenza virus A & Influenza virus B & SARS coronavirus+SARS coronavirus 2 Ag panel
    97099-6Influenza virus A & Influenza virus B & SARS coronavirus 2 Ag panel
    95941-1Influenza virus A & Influenza virus B & SARS coronavirus 2 & Respiratory syncytial virus RNA panel
    95380-2Influenza virus A & Influenza virus B & SARS coronavirus 2 & SARS-related coronavirus RNA panel
    95423-0Influenza virus A & Influenza virus B & SARS coronavirus 2 identified
    95422-2Influenza virus A & Influenza virus B & SARS coronavirus 2 RNA panel
    100345-8Influenza virus A & Influenza virus B & SARS coronavirus 2 RNA panel
    98733-9Percent neutralization by SARS coronavirus 2 spike protein RBD Ab.neut
    99771-8SARS coronavirus 2 spike & nucleocapsid protein stimulated gamma interferon panel
    98846-9SARS coronavirus 2 stimulated gamma interferon release by Helper (CD4+) T-cells^^corrected for background
    98847-7SARS coronavirus 2 stimulated gamma interferon release by lymphocytes^^corrected for background
    99774-2SARS coronavirus 2 stimulated gamma interferon release by T-cells.Nucleocapsid Ag spot count^^corrected for background
    99773-4SARS coronavirus 2 stimulated gamma interferon release by T-cells.Spike Ag spot count^^corrected for background
    95209-3SARS coronavirus+SARS coronavirus 2 Ag
    94763-0SARS coronavirus 2
    94661-6SARS coronavirus 2 Ab
    95825-6SARS coronavirus 2 Ab
    98069-8SARS coronavirus 2 Ab
    94762-2SARS coronavirus 2 Ab
    95542-7SARS coronavirus 2 Ab
    94769-7SARS coronavirus 2 Ab
    96118-5SARS coronavirus 2 Ab panel
    94504-8SARS coronavirus 2 Ab panel
    94503-0SARS coronavirus 2 Ab panel
    94558-4SARS coronavirus 2 Ag
    96119-3SARS coronavirus 2 Ag
    97097-0SARS coronavirus 2 Ag
    96094-8SARS coronavirus 2 & SARS-related coronavirus RNA panel
    98080-5SARS coronavirus 2 & SARS-related coronavirus RNA panel
    96896-6SARS coronavirus 2 clade
    96764-6SARS coronavirus 2 E gene
    96763-8SARS coronavirus 2 E gene
    94562-6SARS coronavirus 2 Ab.IgA
    94768-9SARS coronavirus 2 Ab.IgA
    95427-1SARS coronavirus 2 Ab.IgA
    94720-0SARS coronavirus 2 Ab.IgA
    95125-1SARS coronavirus 2 Ab.IgA+IgM
    96742-2SARS coronavirus 2 Ab.IgG
    94761-4SARS coronavirus 2 Ab.IgG
    94563-4SARS coronavirus 2 Ab.IgG
    94507-1SARS coronavirus 2 Ab.IgG
    95429-7SARS coronavirus 2 Ab.IgG
    94505-5SARS coronavirus 2 Ab.IgG
    94547-7SARS coronavirus 2 Ab.IgG+IgM
    95416-4SARS coronavirus 2 Ab.IgM
    94564-2SARS coronavirus 2 Ab.IgM
    94508-9SARS coronavirus 2 Ab.IgM
    95428-9SARS coronavirus 2 Ab.IgM
    94506-3SARS coronavirus 2 Ab.IgM
    96895-8SARS coronavirus 2 lineage
    100157-7SARS coronavirus 2 lineage
    96957-6SARS coronavirus 2 M gene
    103557-5SARS coronavirus 2 Mpro gene mutation detected
    95521-1SARS coronavirus 2 N gene
    96898-2SARS coronavirus 2 N gene
    94510-5SARS coronavirus 2 N gene
    94311-8SARS coronavirus 2 N gene
    94312-6SARS coronavirus 2 N gene
    95522-9SARS coronavirus 2 N gene
    94760-6SARS coronavirus 2 N gene
    96986-5SARS coronavirus 2 N gene
    95409-9SARS coronavirus 2 N gene
    94533-7SARS coronavirus 2 N gene
    94756-4SARS coronavirus 2 N gene
    94757-2SARS coronavirus 2 N gene
    95425-5SARS coronavirus 2 N gene
    96448-6SARS coronavirus 2 N gene
    96958-4SARS coronavirus 2 N gene
    94766-3SARS coronavirus 2 N gene
    94316-7SARS coronavirus 2 N gene
    94307-6SARS coronavirus 2 N gene
    94308-4SARS coronavirus 2 N gene
    99596-9SARS coronavirus 2 nucleocapsid protein Ab.IgG
    95411-5SARS coronavirus 2 Ab.neut
    95410-7SARS coronavirus 2 Ab.neut
    97098-8SARS coronavirus 2 Nsp2 gene
    98132-4SARS coronavirus 2 ORF1a region
    98494-8SARS coronavirus 2 ORF1a region
    96899-0SARS coronavirus 2 ORF1ab region
    94644-2SARS coronavirus 2 ORF1ab region
    94511-3SARS coronavirus 2 ORF1ab region
    94559-2SARS coronavirus 2 ORF1ab region
    95824-9SARS coronavirus 2 ORF1ab region
    94639-2SARS coronavirus 2 ORF1ab region
    97104-4SARS coronavirus 2 ORF1ab region
    98131-6SARS coronavirus 2 ORF1b region
    98493-0SARS coronavirus 2 ORF1b region
    94646-7SARS coronavirus 2 RdRp gene
    94645-9SARS coronavirus 2 RdRp gene
    96120-1SARS coronavirus 2 RdRp gene
    94534-5SARS coronavirus 2 RdRp gene
    96091-4SARS coronavirus 2 RdRp gene
    94314-2SARS coronavirus 2 RdRp gene
    96123-5SARS coronavirus 2 RdRp gene
    99314-7SARS coronavirus 2 RdRp gene mutation detected
    94745-7SARS coronavirus 2 RNA
    94746-5SARS coronavirus 2 RNA
    94819-0SARS coronavirus 2 RNA
    94565-9SARS coronavirus 2 RNA
    94759-8SARS coronavirus 2 RNA
    95406-5SARS coronavirus 2 RNA
    96797-6SARS coronavirus 2 RNA
    95608-6SARS coronavirus 2 RNA
    94500-6SARS coronavirus 2 RNA
    95424-8SARS coronavirus 2 RNA
    94845-5SARS coronavirus 2 RNA
    94822-4SARS coronavirus 2 RNA
    94660-8SARS coronavirus 2 RNA
    94309-2SARS coronavirus 2 RNA
    96829-7SARS coronavirus 2 RNA
    96897-4SARS coronavirus 2 RNA panel
    94531-1SARS coronavirus 2 RNA panel
    95826-4SARS coronavirus 2 RNA panel
    94306-8SARS coronavirus 2 RNA panel
    96900-6SARS coronavirus 2 S gene
    94642-6SARS coronavirus 2 S gene
    94643-4SARS coronavirus 2 S gene
    94640-0SARS coronavirus 2 S gene
    95609-4SARS coronavirus 2 S gene
    96765-3SARS coronavirus 2 S gene
    94767-1SARS coronavirus 2 S gene
    94641-8SARS coronavirus 2 S gene
    96752-1SARS coronavirus 2 S gene mutation
    96751-3SARS coronavirus 2 S gene mutation detected
    99597-7SARS coronavirus 2 spike protein Ab.IgG
    96603-6SARS coronavirus 2 spike protein RBD Ab.neut
    98732-1SARS coronavirus 2 spike protein RBD Ab.neut
    98734-7SARS coronavirus 2 spike protein RBD Ab.neut
    96894-1SARS coronavirus 2 sequencing & identification panel
    95970-0SARS coronavirus 2 specific TCRB gene rearrangements
    100156-9SARS coronavirus 2 variant
    96741-4SARS coronavirus 2 variant
    96755-4SARS coronavirus 2 variant interpretation
    94764-8SARS coronavirus 2 whole genome
    99772-6SARS coronavirus 2 stimulated gamma interferon
    95971-8SARS coronavirus 2 stimulated gamma interferon
    95974-2SARS coronavirus 2 stimulated gamma interferon panel
    95972-6SARS coronavirus 2 stimulated gamma interferon release by T-cells^^corrected for background
    95973-4SARS coronavirus 2 stimulated gamma interferon release by T-cells
    94509-7SARS-related coronavirus E gene
    96121-9SARS-related coronavirus E gene
    94758-0SARS-related coronavirus E gene
    95823-1SARS-related coronavirus E gene
    94765-5SARS-related coronavirus E gene
    94315-9SARS-related coronavirus E gene
    96122-7SARS-related coronavirus E gene
    94313-4SARS-related coronavirus N gene
    94310-0SARS-related coronavirus N gene
    94502-2SARS-related coronavirus RNA
    94647-5SARS-related coronavirus RNA
    94532-9SARS-related coronavirus+MERS coronavirus RNA
    100342-5Volatile Organic Compounds associated with SARS-CoV-2 infection
    100972-9Influenza virus A and Influenza virus B and SARS coronavirus 2 RNA panel - Nose by NAA with non-probe detection
  • Include these codes as defined in http://www.ama-assn.org/go/cpt
    CodeDisplay
    87637 Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), influenza virus types A and B, and respiratory syncytial virus, multiplex amplified probe technique
    87631 Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when perfor
    87632 Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when perfor
    87633 Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when perfor
    87635 Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique
    87636 Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) and influenza virus types A and B, multiplex amplified probe technique
    0241U Infectious disease (viral respiratory tract infection), pathogen-specific RNA, 4 targets (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2], influenza A, influenza B, respiratory syncytial virus [RSV]), upper respiratory specimen, each pathogen
    87635 Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique
    87636 Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) and influenza virus types A and B, multiplex amplified probe technique
    87637 Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), influenza virus types A and B, and respiratory syncytial virus, multiplex amplified probe technique
    86328 Immunoassay for infectious agent antibody(ies), qualitative or semiquantitative, single step method (eg, reagent strip); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19])
    86408 Neutralizing antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]); screen
    86409 Neutralizing antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]); titer
    86413 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) antibody, quantitative
    87811 Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19])
    0224U Antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), includes titer(s), when performed
    0226U Surrogate viral neutralization test (sVNT), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), ELISA, plasma, serum
    0202U Infectious disease (bacterial or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 22 targets including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), qualitative RT-PCR, nasopharyngeal swab, each pathogen rep
    0223U Infectious disease (bacterial or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 22 targets including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), qualitative RT-PCR, nasopharyngeal swab, each pathogen rep
    0225U Infectious disease (bacterial or viral respiratory tract infection) pathogen-specific DNA and RNA, 21 targets, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), amplified probe technique, including multiplex reverse transcription for
    87913 Infectious agent genotype analysis by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), mutation identification in targeted region(s)
    0240U Detection of SARS-CoV-2, Influenza A and Influenza B
    87426 Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative; severe acute resp
    87428 Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative; severe acute resp
    86318 Immunoassay for infectious agent antibody(ies) and to be a parent to 86328
    87252 Viral Culture, General; Virus isolation; tissue culture inoculation, observation, and presumptive identification by cytopathic effect

 

Expansion

Expansion from tx.fhir.org based on:

  • Loinc v2.80
  • codesystem Current Procedural Terminology (CPT®) version2023

This value set has 187 codes in it. In order to keep the publication size manageable, only a selection (183 codes) of the whole set of codes is shown.

CodeSystemDisplay (en-US)
  102048-6http://loinc.orgSARS coronavirus 2 and Respiratory syncytial virus Ag [Presence] in Nasopharynx by Immunofluorescence
  95941-1http://loinc.orgInfluenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
  100861-4http://loinc.orgCells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide
  100858-0http://loinc.orgCells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide
  100862-2http://loinc.orgCells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide
  100859-8http://loinc.orgCells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide
  100863-0http://loinc.orgCells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide
  100860-6http://loinc.orgCells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide
  95942-9http://loinc.orgInfluenza virus A and B and SARS-CoV+SARS-CoV-2 (COVID-19) Ag panel - Upper respiratory specimen by Rapid immunoassay
  97099-6http://loinc.orgInfluenza virus A and B and SARS-CoV-2 (COVID-19) Ag panel - Upper respiratory specimen by Rapid immunoassay
  95380-2http://loinc.orgInfluenza virus A and B and SARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel - Respiratory system specimen by NAA with probe detection
  95423-0http://loinc.orgInfluenza virus A and B and SARS-CoV-2 (COVID-19) identified in Respiratory system specimen by NAA with probe detection
  95422-2http://loinc.orgInfluenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel - Respiratory system specimen by NAA with probe detection
  100345-8http://loinc.orgInfluenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection
  98733-9http://loinc.orgPercent neutralization by SARS coronavirus 2 spike protein RBD neutralizing antibody in Serum or Plasma by Immunoassay
  99771-8http://loinc.orgSARS coronavirus 2 spike and nucleocapsid protein stimulated gamma interferon panel - Blood
  98846-9http://loinc.orgSARS coronavirus 2 stimulated gamma interferon release by Helper (CD4+) T-cells [Units/volume] corrected for background in Blood by Immunoassay
  98847-7http://loinc.orgSARS coronavirus 2 stimulated gamma interferon release by lymphocytes [Units/volume] corrected for background in Blood by Immunoassay
  99774-2http://loinc.orgSARS coronavirus 2 stimulated gamma interferon release by T-cells.Nucleocapsid Ag spot count [#] corrected for background in Blood
  99773-4http://loinc.orgSARS coronavirus 2 stimulated gamma interferon release by T-cells.Spike Ag spot count [#] corrected for background in Blood
  95209-3http://loinc.orgSARS-CoV+SARS-CoV-2 (COVID-19) Ag [Presence] in Respiratory system specimen by Rapid immunoassay
  94763-0http://loinc.orgSARS-CoV-2 (COVID-19) [Presence] in Specimen by Organism specific culture
  94661-6http://loinc.orgSARS-CoV-2 (COVID-19) Ab [Interpretation] in Serum or Plasma
  95825-6http://loinc.orgSARS-CoV-2 (COVID-19) Ab [Presence] in DBS by Immunoassay
  98069-8http://loinc.orgSARS-CoV-2 (COVID-19) Ab [Presence] in Saliva (oral fluid) by Rapid immunoassay
  94762-2http://loinc.orgSARS-CoV-2 (COVID-19) Ab [Presence] in Serum or Plasma by Immunoassay
  95542-7http://loinc.orgSARS-CoV-2 (COVID-19) Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
  94769-7http://loinc.orgSARS-CoV-2 (COVID-19) Ab [Units/volume] in Serum or Plasma by Immunoassay
  96118-5http://loinc.orgSARS-CoV-2 (COVID-19) Ab panel - DBS by Immunoassay
  94504-8http://loinc.orgSARS-CoV-2 (COVID-19) Ab panel - Serum or Plasma by Immunoassay
  94503-0http://loinc.orgSARS-CoV-2 (COVID-19) Ab panel - Serum, Plasma or Blood by Rapid immunoassay
  94558-4http://loinc.orgSARS-CoV-2 (COVID-19) Ag [Presence] in Respiratory system specimen by Rapid immunoassay
  96119-3http://loinc.orgSARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
  97097-0http://loinc.orgSARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
  96094-8http://loinc.orgSARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel - Respiratory system specimen by NAA with probe detection
  98080-5http://loinc.orgSARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel - Saliva (oral fluid) by NAA with probe detection
  96896-6http://loinc.orgSARS-CoV-2 (COVID-19) clade [Type] in Specimen by Molecular genetics method
  96764-6http://loinc.orgSARS-CoV-2 (COVID-19) E gene [Cycle Threshold #] in Respiratory system specimen by NAA with probe detection
  96763-8http://loinc.orgSARS-CoV-2 (COVID-19) E gene [Presence] in Respiratory system specimen by NAA with probe detection
  94562-6http://loinc.orgSARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
  94768-9http://loinc.orgSARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
  95427-1http://loinc.orgSARS-CoV-2 (COVID-19) IgA Ab [Titer] in Serum or Plasma by Immunofluorescence
  94720-0http://loinc.orgSARS-CoV-2 (COVID-19) IgA Ab [Units/volume] in Serum or Plasma by Immunoassay
  95125-1http://loinc.orgSARS-CoV-2 (COVID-19) IgA+IgM [Presence] in Serum or Plasma by Immunoassay
  96742-2http://loinc.orgSARS-CoV-2 (COVID-19) IgG Ab [Mass/volume] in Serum or Plasma by Immunoassay
  94761-4http://loinc.orgSARS-CoV-2 (COVID-19) IgG Ab [Presence] in DBS by Immunoassay
  94563-4http://loinc.orgSARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
  94507-1http://loinc.orgSARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
  95429-7http://loinc.orgSARS-CoV-2 (COVID-19) IgG Ab [Titer] in Serum or Plasma by Immunofluorescence
  94505-5http://loinc.orgSARS-CoV-2 (COVID-19) IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
  94547-7http://loinc.orgSARS-CoV-2 (COVID-19) IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay
  95416-4http://loinc.orgSARS-CoV-2 (COVID-19) IgM Ab [Presence] in DBS by Immunoassay
  94564-2http://loinc.orgSARS-CoV-2 (COVID-19) IgM Ab [Presence] in Serum or Plasma by Immunoassay
  94508-9http://loinc.orgSARS-CoV-2 (COVID-19) IgM Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
  95428-9http://loinc.orgSARS-CoV-2 (COVID-19) IgM Ab [Titer] in Serum or Plasma by Immunofluorescence
  94506-3http://loinc.orgSARS-CoV-2 (COVID-19) IgM Ab [Units/volume] in Serum or Plasma by Immunoassay
  96895-8http://loinc.orgSARS-CoV-2 (COVID-19) lineage [Identifier] in Specimen by Molecular genetics method
  100157-7http://loinc.orgSARS-CoV-2 (COVID-19) lineage [Type] in Specimen by Sequencing
  96957-6http://loinc.orgSARS-CoV-2 (COVID-19) M gene [Presence] in Upper respiratory specimen by NAA with probe detection
  103557-5http://loinc.orgSARS-CoV-2 (COVID-19) Mpro gene mutation detected [Identifier] in Specimen by Molecular genetics method Nominal
  95521-1http://loinc.orgSARS-CoV-2 (COVID-19) N gene [#/volume] (viral load) in Respiratory system specimen by NAA with probe detection
  96898-2http://loinc.orgSARS-CoV-2 (COVID-19) N gene [Cycle Threshold #] in Oropharyngeal wash by NAA with probe detection
  94510-5http://loinc.orgSARS-CoV-2 (COVID-19) N gene [Cycle Threshold #] in Specimen by NAA with probe detection
  94311-8http://loinc.orgSARS-CoV-2 (COVID-19) N gene [Cycle Threshold #] in Specimen by Nucleic acid amplification using CDC primer-probe set N1
  94312-6http://loinc.orgSARS-CoV-2 (COVID-19) N gene [Cycle Threshold #] in Specimen by Nucleic acid amplification using CDC primer-probe set N2
  95522-9http://loinc.orgSARS-CoV-2 (COVID-19) N gene [Log #/volume] (viral load) in Respiratory system specimen by NAA with probe detection
  94760-6http://loinc.orgSARS-CoV-2 (COVID-19) N gene [Presence] in Nasopharynx by NAA with probe detection
  96986-5http://loinc.orgSARS-CoV-2 (COVID-19) N gene [Presence] in Nose by NAA with non-probe detection
  95409-9http://loinc.orgSARS-CoV-2 (COVID-19) N gene [Presence] in Nose by NAA with probe detection
  94533-7http://loinc.orgSARS-CoV-2 (COVID-19) N gene [Presence] in Respiratory system specimen by NAA with probe detection
  94756-4http://loinc.orgSARS-CoV-2 (COVID-19) N gene [Presence] in Respiratory system specimen by Nucleic acid amplification using CDC primer-probe set N1
  94757-2http://loinc.orgSARS-CoV-2 (COVID-19) N gene [Presence] in Respiratory system specimen by Nucleic acid amplification using CDC primer-probe set N2
  95425-5http://loinc.orgSARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by NAA with probe detection
  96448-6http://loinc.orgSARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by Nucleic acid amplification using CDC primer-probe set N1
  96958-4http://loinc.orgSARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by Nucleic acid amplification using CDC primer-probe set N2
  94766-3http://loinc.orgSARS-CoV-2 (COVID-19) N gene [Presence] in Serum or Plasma by NAA with probe detection
  94316-7http://loinc.orgSARS-CoV-2 (COVID-19) N gene [Presence] in Specimen by NAA with probe detection
  94307-6http://loinc.orgSARS-CoV-2 (COVID-19) N gene [Presence] in Specimen by Nucleic acid amplification using CDC primer-probe set N1
  94308-4http://loinc.orgSARS-CoV-2 (COVID-19) N gene [Presence] in Specimen by Nucleic acid amplification using CDC primer-probe set N2
  99596-9http://loinc.orgSARS-CoV-2 (COVID-19) N protein IgG Ab [Presence] in Serum or Plasma by Immunoassay
  95411-5http://loinc.orgSARS-CoV-2 (COVID-19) neutralizing antibody [Presence] in Serum by pVNT
  95410-7http://loinc.orgSARS-CoV-2 (COVID-19) neutralizing antibody [Titer] in Serum by pVNT
  97098-8http://loinc.orgSARS-CoV-2 (COVID-19) Nsp2 gene [Presence] in Upper respiratory specimen by NAA with probe detection
  98132-4http://loinc.orgSARS-CoV-2 (COVID-19) ORF1a region [Presence] in Respiratory system specimen by NAA with probe detection
  98494-8http://loinc.orgSARS-CoV-2 (COVID-19) ORF1a region [Presence] in Saliva (oral fluid) by NAA with probe detection
  96899-0http://loinc.orgSARS-CoV-2 (COVID-19) ORF1ab region [Cycle Threshold #] in Oropharyngeal wash by NAA with probe detection
  94644-2http://loinc.orgSARS-CoV-2 (COVID-19) ORF1ab region [Cycle Threshold #] in Respiratory system specimen by NAA with probe detection
  94511-3http://loinc.orgSARS-CoV-2 (COVID-19) ORF1ab region [Cycle Threshold #] in Specimen by NAA with probe detection
  94559-2http://loinc.orgSARS-CoV-2 (COVID-19) ORF1ab region [Presence] in Respiratory system specimen by NAA with probe detection
  95824-9http://loinc.orgSARS-CoV-2 (COVID-19) ORF1ab region [Presence] in Saliva (oral fluid) by NAA with probe detection
  94639-2http://loinc.orgSARS-CoV-2 (COVID-19) ORF1ab region [Presence] in Specimen by NAA with probe detection
  97104-4http://loinc.orgSARS-CoV-2 (COVID-19) ORF1ab region [Units/volume] (viral load) in Upper respiratory specimen by NAA with probe detection
  98131-6http://loinc.orgSARS-CoV-2 (COVID-19) ORF1b region [Presence] in Respiratory system specimen by NAA with probe detection
  98493-0http://loinc.orgSARS-CoV-2 (COVID-19) ORF1b region [Presence] in Saliva (oral fluid) by NAA with probe detection
  94646-7http://loinc.orgSARS-CoV-2 (COVID-19) RdRp gene [Cycle Threshold #] in Respiratory system specimen by NAA with probe detection
  94645-9http://loinc.orgSARS-CoV-2 (COVID-19) RdRp gene [Cycle Threshold #] in Specimen by NAA with probe detection
  96120-1http://loinc.orgSARS-CoV-2 (COVID-19) RdRp gene [Presence] in Lower respiratory specimen by NAA with probe detection
  94534-5http://loinc.orgSARS-CoV-2 (COVID-19) RdRp gene [Presence] in Respiratory system specimen by NAA with probe detection
  96091-4http://loinc.orgSARS-CoV-2 (COVID-19) RdRp gene [Presence] in Saliva (oral fluid) by NAA with probe detection
  94314-2http://loinc.orgSARS-CoV-2 (COVID-19) RdRp gene [Presence] in Specimen by NAA with probe detection
  96123-5http://loinc.orgSARS-CoV-2 (COVID-19) RdRp gene [Presence] in Upper respiratory specimen by NAA with probe detection
  99314-7http://loinc.orgSARS-CoV-2 (COVID-19) RdRp gene mutation detected [Identifier] in Specimen by Molecular genetics method
  94745-7http://loinc.orgSARS-CoV-2 (COVID-19) RNA [Cycle Threshold #] in Respiratory system specimen by NAA with probe detection
  94746-5http://loinc.orgSARS-CoV-2 (COVID-19) RNA [Cycle Threshold #] in Specimen by NAA with probe detection
  94819-0http://loinc.orgSARS-CoV-2 (COVID-19) RNA [Log #/volume] (viral load) in Specimen by NAA with probe detection
  94565-9http://loinc.orgSARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with non-probe detection
  94759-8http://loinc.orgSARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
  95406-5http://loinc.orgSARS-CoV-2 (COVID-19) RNA [Presence] in Nose by NAA with probe detection
  96797-6http://loinc.orgSARS-CoV-2 (COVID-19) RNA [Presence] in Oropharyngeal wash by NAA with probe detection
  95608-6http://loinc.orgSARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with non-probe detection
  94500-6http://loinc.orgSARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
  95424-8http://loinc.orgSARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by Sequencing
  94845-5http://loinc.orgSARS-CoV-2 (COVID-19) RNA [Presence] in Saliva (oral fluid) by NAA with probe detection
  94822-4http://loinc.orgSARS-CoV-2 (COVID-19) RNA [Presence] in Saliva (oral fluid) by Sequencing
  94660-8http://loinc.orgSARS-CoV-2 (COVID-19) RNA [Presence] in Serum or Plasma by NAA with probe detection
  94309-2http://loinc.orgSARS-CoV-2 (COVID-19) RNA [Presence] in Specimen by NAA with probe detection
  96829-7http://loinc.orgSARS-CoV-2 (COVID-19) RNA [Presence] in Specimen from Donor by NAA with probe detection
  96897-4http://loinc.orgSARS-CoV-2 (COVID-19) RNA panel - Oropharyngeal wash by NAA with probe detection
  94531-1http://loinc.orgSARS-CoV-2 (COVID-19) RNA panel - Respiratory system specimen by NAA with probe detection
  95826-4http://loinc.orgSARS-CoV-2 (COVID-19) RNA panel - Saliva (oral fluid) by NAA with probe detection
  94306-8http://loinc.orgSARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection
  96900-6http://loinc.orgSARS-CoV-2 (COVID-19) S gene [Cycle Threshold #] in Oropharyngeal wash by NAA with probe detection
  94642-6http://loinc.orgSARS-CoV-2 (COVID-19) S gene [Cycle Threshold #] in Respiratory system specimen by NAA with probe detection
  94643-4http://loinc.orgSARS-CoV-2 (COVID-19) S gene [Cycle Threshold #] in Specimen by NAA with probe detection
  94640-0http://loinc.orgSARS-CoV-2 (COVID-19) S gene [Presence] in Respiratory system specimen by NAA with probe detection
  95609-4http://loinc.orgSARS-CoV-2 (COVID-19) S gene [Presence] in Respiratory system specimen by Sequencing
  96765-3http://loinc.orgSARS-CoV-2 (COVID-19) S gene [Presence] in Saliva (oral fluid) by NAA with probe detection
  94767-1http://loinc.orgSARS-CoV-2 (COVID-19) S gene [Presence] in Serum or Plasma by NAA with probe detection
  94641-8http://loinc.orgSARS-CoV-2 (COVID-19) S gene [Presence] in Specimen by NAA with probe detection
  96752-1http://loinc.orgSARS-CoV-2 (COVID-19) S gene mutation [Presence] in Specimen by Molecular genetics method
  96751-3http://loinc.orgSARS-CoV-2 (COVID-19) S gene mutation detected [Identifier] in Specimen by Molecular genetics method
  99597-7http://loinc.orgSARS-CoV-2 (COVID-19) S protein IgG Ab [Presence] in Serum or Plasma by Immunoassay
  96603-6http://loinc.orgSARS-CoV-2 (COVID-19) S protein RBD neutralizing antibody [Presence] in Serum or Plasma by sVNT
  98732-1http://loinc.orgSARS-CoV-2 (COVID-19) S protein RBD neutralizing antibody [Titer] in Serum or Plasma by Immunoassay
  98734-7http://loinc.orgSARS-CoV-2 (COVID-19) S protein RBD neutralizing antibody [Units/volume] in Serum or Plasma by Immunoassay
  96894-1http://loinc.orgSARS-CoV-2 (COVID-19) sequencing and identification panel - Specimen by Molecular genetics method
  95970-0http://loinc.orgSARS-CoV-2 (COVID-19) specific TCRB gene rearrangements [Presence] in Blood by Sequencing
  100156-9http://loinc.orgSARS-CoV-2 (COVID-19) variant [Type] in Specimen by NAA with probe detection
  96741-4http://loinc.orgSARS-CoV-2 (COVID-19) variant [Type] in Specimen by Sequencing
  96755-4http://loinc.orgSARS-CoV-2 (COVID-19) variant interpretation in Specimen Narrative
  94764-8http://loinc.orgSARS-CoV-2 (COVID-19) whole genome [Nucleotide sequence] in Isolate or Specimen by Sequencing
  99772-6http://loinc.orgSARS-CoV-2 stimulated gamma interferon [Interpretation] in Blood Qualitative
  95971-8http://loinc.orgSARS-CoV-2 stimulated gamma interferon [Presence] in Blood
  95974-2http://loinc.orgSARS-CoV-2 stimulated gamma interferon panel - Blood
  95972-6http://loinc.orgSARS-CoV-2 stimulated gamma interferon release by T-cells [Units/volume] corrected for background in Blood
  95973-4http://loinc.orgSARS-CoV-2 stimulated gamma interferon release by T-cells [Units/volume] in Blood
  94509-7http://loinc.orgSARS-related coronavirus E gene [Cycle Threshold #] in Specimen by NAA with probe detection
  96121-9http://loinc.orgSARS-related coronavirus E gene [Presence] in Lower respiratory specimen by NAA with probe detection
  94758-0http://loinc.orgSARS-related coronavirus E gene [Presence] in Respiratory system specimen by NAA with probe detection
  95823-1http://loinc.orgSARS-related coronavirus E gene [Presence] in Saliva (oral fluid) by NAA with probe detection
  94765-5http://loinc.orgSARS-related coronavirus E gene [Presence] in Serum or Plasma by NAA with probe detection
  94315-9http://loinc.orgSARS-related coronavirus E gene [Presence] in Specimen by NAA with probe detection
  96122-7http://loinc.orgSARS-related coronavirus E gene [Presence] in Upper respiratory specimen by NAA with probe detection
  94313-4http://loinc.orgSARS-related coronavirus N gene [Cycle Threshold #] in Specimen by Nucleic acid amplification using CDC primer-probe set N3
  94310-0http://loinc.orgSARS-related coronavirus N gene [Presence] in Specimen by Nucleic acid amplification using CDC primer-probe set N3
  94502-2http://loinc.orgSARS-related coronavirus RNA [Presence] in Respiratory system specimen by NAA with probe detection
  94647-5http://loinc.orgSARS-related coronavirus RNA [Presence] in Specimen by NAA with probe detection
  94532-9http://loinc.orgSARS-related coronavirus+MERS coronavirus RNA [Presence] in Respiratory system specimen by NAA with probe detection
  100342-5http://loinc.orgVolatile Organic Compounds associated with SARS-CoV-2 infection [Presence] in Exhaled gas by Gas chromatography-mass spectrometry
  100972-9http://loinc.orgInfluenza virus A and Influenza virus B and SARS coronavirus 2 RNA panel - Nose by NAA with non-probe detection
  87637http://www.ama-assn.org/go/cptInfectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), influenza virus types A and B, and respiratory syncytial virus, multiplex amplified probe technique
  87631http://www.ama-assn.org/go/cptInfectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 3-5 targets
  87632http://www.ama-assn.org/go/cptInfectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 6-11 targets
  87633http://www.ama-assn.org/go/cptInfectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 12-25 targets
  87635http://www.ama-assn.org/go/cptInfectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique
  87636http://www.ama-assn.org/go/cptInfectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) and influenza virus types A and B, multiplex amplified probe technique
  0241Uhttp://www.ama-assn.org/go/cptRespiratory infectious agent detection by RNA for severe acute respiratory syndrome coronavirus 2 (COVID 19), influenza A, influenza B, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected
  86328http://www.ama-assn.org/go/cptImmunoassay for infectious agent antibody(ies), qualitative or semiquantitative, single-step method (eg, reagent strip); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19])
  86408http://www.ama-assn.org/go/cptNeutralizing antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]); screen
  86409http://www.ama-assn.org/go/cptNeutralizing antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]); titer
  86413http://www.ama-assn.org/go/cptSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) antibody, quantitative
  87811http://www.ama-assn.org/go/cptInfectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19])
  0224Uhttp://www.ama-assn.org/go/cptMeasurement of antibody to severe acute respiratory syndrome coronavirus 2 (COVID-19)
  0226Uhttp://www.ama-assn.org/go/cptSurrogate viral neutralization test (sVNT) for detection of antibodies to severe acute respiratory syndrome coronavirus 2 (Covid-19) by
  0202Uhttp://www.ama-assn.org/go/cptTest for detection of respiratory disease-causing organisms from back of nose and throat (nasopharynx) specimen, 22 target organisms including severe acute respiratory syndrome coronavirus 2
  0223Uhttp://www.ama-assn.org/go/cptTest for detection of respiratory disease-causing organisms from back of nose and throat (nasopharynx) specimen, 22 target organisms including severe acute respiratory syndrome coronavirus 2
  0225Uhttp://www.ama-assn.org/go/cptTest for detection of respiratory disease-causing organisms, 21 target organisms including severe acute respiratory syndrome coronavirus 2 (COVID-19)
  87913http://www.ama-assn.org/go/cptInfectious agent genotype analysis by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), mutation identification in targeted region(s)
  0240Uhttp://www.ama-assn.org/go/cptRespiratory infectious agent detection by RNA for severe acute respiratory syndrome coronavirus 2 (COVID-19), influenza A, and influenza B) in upper respiratory specimen, each reported as detected or not detected
  87426http://www.ama-assn.org/go/cptInfectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; severe acute respiratory syndrome coronavirus (eg, SARS-CoV, SARS-CoV-2 [COVID-19])
  87428http://www.ama-assn.org/go/cptInfectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; severe acute respiratory syndrome coronavirus (eg, SARS-CoV, SARS-CoV-2 [COVID-19]) and influenza virus types A and B
  86318http://www.ama-assn.org/go/cptImmunoassay for infectious agent antibody(ies), qualitative or semiquantitative, single-step method (eg, reagent strip);
  87252http://www.ama-assn.org/go/cptVirus isolation; tissue culture inoculation, observation, and presumptive identification by cytopathic effect

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code